e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Discussion of vaccines, biomarkers and risk factors analysis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intrahospital cardiovascular complications in severe community-acquired pneumonia
A. Cilli (Antalya, Turkey)
Source:
International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Session:
Discussion of vaccines, biomarkers and risk factors analysis
Session type:
Poster Discussion
Number:
4522
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Cilli (Antalya, Turkey). Intrahospital cardiovascular complications in severe community-acquired pneumonia. 4522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Biomarkers and cardiovascular events in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Affecting factors of mortality in severe community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia
Source: Eur Respir J 2009; 34: 932-939
Year: 2009
Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009
Nosocomial superinfection is one of the principal cause of mortality in severe community-acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Severe community-acquired pneumonia
Source: Eur Respir Monogr 2016; 74: 101-116
Year: 2016
Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections
Source: Eur Respir Monogr 2020; 88: 212-228
Year: 2020
Analysis of the mortality caused by community-acquired pneumonia in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 544s
Year: 2005
Community-acquired pneumonia: treatment failure and complications
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Community-acquired pneumonia in the elderly requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 413s
Year: 2004
Preventing community-acquired pneumonia
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Analysis of mortality from community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 376s
Year: 2006
Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Particularities of community-acquired pneumonia in the elderly
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept